Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
about
Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantationPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT.Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicityVoriconazole in clinical practice.Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature.Antifungal agents and liver toxicity: a complex interaction.Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.Hepatotoxicity of Antimycotics Used for Invasive Fungal Infections: In Vitro Results.Switching to anidulafungin from caspofungin in cancer patients in the setting of liver dysfunction is associated with improvement of liver function tests.Drug-induced liver injury after allogeneic bone marrow transplantation.Long-term voriconazole and skin cancer: is there cause for concern?Risk Factors for Voriconazole-Associated Hepatotoxicity in Patients in the Intensive Care Unit.Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.
P2860
Q34452574-DEA15D80-F31E-41E9-A06D-F35B7F9BC10FQ34532546-D12316A9-3442-474A-9CA2-FAACC6126008Q35231368-E5421249-2FFB-4B7A-9B65-048B3CACC5EEQ35941502-F9F6294A-F70A-4673-8039-A549B4CEF88CQ38061736-EA70DBCE-4D47-4401-AF60-8E92F5E0CC5DQ38202288-80DAACBC-690C-4EF9-B969-5CDE73765345Q38858839-F2381333-8FB8-44CC-B6C7-917456A7B2D3Q39479653-04BAC477-F2D1-4151-B562-9B7EC2245797Q40225550-0BD6EA3A-7772-4377-AD6F-3E44EE5F426FQ41031277-A0C129F4-E7B3-4A2D-A4DB-32C382C0EE03Q44293383-1E39AB94-C475-4AF1-B124-A2F320AD7C7AQ45247488-270FE425-26D2-4C13-B8AD-A6EA55374FA0Q45263865-5D88A77F-82EE-46F1-89D0-D46F834B3A41Q47205373-56ECB936-8805-47D0-A908-461434B7B8C2
P2860
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
@ast
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
@en
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
@nl
type
label
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
@ast
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
@en
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
@nl
prefLabel
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
@ast
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
@en
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
@nl
P2093
P2860
P1476
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation
@en
P2093
A Jakubowski
P2860
P356
10.1016/J.BBMT.2009.08.015
P577
2009-10-09T00:00:00Z